Skip to content

Lifecore Biomedical, Inc. LFCR Balance Sheet Statement

TTM Q4 '26TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25
$8.27M-2.3%
$8M
$32.29M-22.0%
$85.68M+5.7%
$129.01M-13.5%
$13.88M0.0%
$239.34M-5.8%
$8.22M-49.7%
$3.44M+264%
$30.18M-22.4%
$191.91M-4.1%
37K+19.4%
-$205.24M-23.3%
-$28.44M-2,229%-$14.2M-737%-$10.54M-168%-$861K+78.1%$1.34M-88.2%
$239.34M-5.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lifecore Biomedical, Inc.'s total assets?
Lifecore Biomedical, Inc. (LFCR) holds $225.5M in total assets, down 5.8% year over year.
How much debt does Lifecore Biomedical, Inc. have?
Lifecore Biomedical, Inc. carries $156.9M in total debt against -$28.4M of shareholders' equity, a debt-to-equity ratio of 8.33.
How much cash does Lifecore Biomedical, Inc. have?
Lifecore Biomedical, Inc. holds $20.8M in cash and equivalents.
Can Lifecore Biomedical, Inc. cover its short-term obligations?
Its current ratio is 3.79 — current assets exceed current liabilities.
Where does Lifecore Biomedical, Inc.'s balance sheet data come from?
Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.